Overview

* Tivic Health ( TIVC ) Q3 revenue rises to $146,000, final quarter for direct ClearUP sales

* Net loss widens to $2.6 mln in Q3, impacted by consumer business wind down

Outlook

* Company did not provide specific financial guidance for future quarters or years

Result Drivers

* MILITARY INTEREST - Tivic advanced discussions on deploying Entolimod as a military countermeasure at MHSRS

* Operating expenses totaled $2.3 million, compared with $1.5 million for the same period in 2024.

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $146,000

Revenue

Q3 Net -$2.60

Income mln

Q3 Basic -$1.97

EPS

Q3 Gross -$145,00

Profit 0

Q3 $2.34

Operatin mln

g

Expenses

Q3 -$2.48

Operatin mln

g Income

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)